Characterization of Klebsiella pneumoniae producing SHV-12 and DHA-1 β-lactamases accompanied by carbapenem resistance during hospitalization in a chronic care ward in Japan

Journal of Chemotherapy

Volumn 21, Issue 4, 2009, Pages 445-447

  Yamada, Yuki ^a   Ishii, Y ^b   Kouyama, Y ^b   Katho, M ^a   Odashiro, R ^a   Yamahata, K ^a   Tateda, K ^b   Yamaguchi, K ^b   Suwabe, A ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE SHV; CARBAPENEM; CEFMETAZOLE; DHA 1 BETA LACTAMASE; UNCLASSIFIED DRUG;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE COURSE; DNA SEQUENCE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; JAPAN; KLEBSIELLA PNEUMONIAE; PROTEIN ANALYSIS; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; WARD;

EID: 70349210174     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2009.21.4.445     Document Type: Article

References (12)

1. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Cli Microbiol Rev. 2005;18(4):657-686.
2. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coll in nursing homes. JAMA. 1999;281(6):517-523. (Pubitemid 29081304)
3. Bell JM, Chitsaz M, Turnidge JD, Barton M, Walters LJ, Jones RN. Prevalence and significance of a negative extended-spectrum β-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program. J Clin Microbiol. 2007;45(5):1478-1482. (Pubitemid 46762401)
4. Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother. 2002;46(1):1-11.
5. Queenan AM and Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev. 2007;20(3):440-458.
6. Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother. 1997;41(3):563-569. (Pubitemid 27098404)
7. Nagano N, Shibata N, Saitou Y, Nagano Y, Arakawa Y. Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type β-Lactamase. J Clin Microbiol. 2003;41(12):5530-5536. (Pubitemid 37543240)
8. Yagi T, Wachino J, Kurokawa H, Suzuki S, Yamane K, Doi Y, et al. Practical methods using boronic acid compounds for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol. 2005;43(6):2551-2558. (Pubitemid 40827918)
9. Yan JJ, Ko WC, Jung YC, Chuang CL, Wu JJ. Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 βlactamase in a university hospital in Taiwan. J Clin Microbiol. 2002;40(9): 3121-3126.
10. Arakawa Y, Shibata N, Shibayama K, Kurokawa H, Yagi T, Fujiwara H, et al. Convenient test for screening metallo-β-lactamase-producing gram-negative bacteria by using thiol compounds. J Clin Microbiol. 2000;38(1):40-43. (Pubitemid 30043261)
11. Chart H, editor. Methods in practical laboratory bacteriology. London, UK: CRC Press; 1994.
12. Tzouvelekis LS, Tzelepi E, Prinarakis E, Gazouli M, Katrahoura A, Giakkoupi P, et al. Sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome in Greek hospitals. J. Clin. Microbiol. 1998;36(1):266-268